Ricardo_maccioni.jpg_thumb90

Ricardo Benjamin Maccioni Baraona

DIRECTOR

CENTRO INTERNACIONAL DE BIOMEDICINA (ICC)

SANTIAGO, Chile

Líneas de Investigación


NEUROSCIENCES; BIOMEDICINE; CELLULAR AND MOLECULAR BIOLOGY; MOLECULAR/CELLULAR STUDIES ON ALZHEIMER´S DISEASE; DEVELOPMENT OF EARLY DIAGNOSIS TOOLS FOR ALZHEIMER'S DISEASE.

Educación

  •  Biochemist, UNIVERSIDAD DE CHILE. Chile, 1969
  •  PhD in Biomedical Science, UNIVERSIDAD DE CHILE. Chile, 1975
  •  Postdoctoral fellowship in Neurological science, NATIONAL INSTITUTE OF HEALTH. Estados Unidos, 1976
  •  Postdoctoral fellowship in Neuroscience, UNIVERSITY OF COLORADO HEALTH SCIENCE CENTER. Estados Unidos, 1978

Experiencia Académica

  •   ASISTANT PROFESSOR Full Time

    UNIVERSITY OF COLORADO

    HEALTH SCIENCE CENTER

    Denver, CO, Estados Unidos

    1981 - 1985

  •   Associate Professor Full Time

    UNIVERSITY OF COLORADO

    HEALTH SCIENCE CENTER

    Denver, CO, Chile

    1986 - 1990

  •   Associate Professor Part Time

    UNIVERSITY OF COLORADO

    HEALTH SCIENCE CENTER

    Denver, CO, Chile

    1986 - 1990

  •   Full Professor of Neurology Part Time

    UNIVERSIDAD DE CHILE

    Medicine

    SANTIAGO, Chile

    2005 - A la fecha

  •   Full Professor Full Time

    UNIVERSIDAD DE CHILE

    Science

    SANTIAGO, Chile

    1990 - A la fecha

  •   DIRECTOR Other

    INTERNATIONAL CENTER FOR BIOMEDICINE ICC

    NEUROSCIENCE

    Santiago, Chile

    1990 - A la fecha

Experiencia Profesional

  •   Director Part Time

    International Center for Biomedicine ICC

    Santiago, Chile

    1989 - A la fecha

  •   Director Part Time

    Millennium Institute for Advanced Studies (CBB)

    Santiago, Chile

    1999 - 2005

  •   Director Part Time

    Mind and Brain Program of the ICC

    Santiago, Chile

    2006 - A la fecha

Formación de Capital Humano


One of the major strength in Academic Career has been the Human Capital Training. Participated as tesis Director of 57 graduate students and 30 biochemists and biotechnologists. In addition, directed 18 International courses in the fields of Neuroscience and Cell Biology.


Difusión y Transferencia


Among the many outreach activities are:
-The organization of over 40 international symposiums and conferences held in Chile, USA and Europe. This includes the Millennium Conference of Dr. Craig Venter in 2003, Santiago - Chile; The EMBO Workshop Symposium in advanced Micrioscopy in Cell Biology, sponsored by EMBO, European Molecular Biology Organization 2003, Santiago - Chile; Scientific Creativity in Alzheimer's Disease 2018, Santiago - Chile; International Conference in Cognitive Neurology 2018, Warsaw - Poland.

-"Workshops series on quality of life for the elderly" 2005-2010, Santiago - Chile, focused on biology of aging and the environmental and nutritional aspects, and style of life for optimal quality of life for the elderly.

- The "Seeds program for education of the high school teachers in science" directed to around 3,000 teachers in the whole country, Chile 2005-2012.


Premios y Distinciones

  •   International NIH Postdoctoral Fellowship Award

    UNIVERSITY OF COLORADO HEALTH SCIENCES

    Estados Unidos, 1975

    Postdoctoral Fellowship Award

  •   Senior EMBO Fellow

    European Molecular Biology Organization (EMBO)

    Alemania, 1984

    Senior EMBO Fellow

  •   Presidential Chair in Science

    President of Chile

    Chile, 1998

    An award to distinguish excellence in cutting-edge research in the area of cell biology and biomedicine. Among most important investigator in Chile.

  •   Alzheimer Award

    Alzheimer's Association

    Estados Unidos, 1999

    An award to distinguish outstanding investigation on the molecular basis of Alzheimer's disease and diagnostic tools for these brain disorders.

  •   Tribute to outstanding research in Alzheimer's disease

    HARVARD UNIVERSITY

    Canada, 2019

    Main keynote speaker and plenary lecturer at the conference "2nd International Conference on Dementia & Dementia Care" Toronto, Canada.


 

Article (123)

Biomarkers for Alzheimer's Disease
CDK5: A Unique CDK and Its Multiple Roles in the Nervous System
The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population
Alzheimer´s Disease in the Perspective of Neuroimmunology
An Overview of the Links between Behavioral Disorder and Alzheimer’s Disease
Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.
The Natural Product Curcumin as a Potential Coadjuvant in Alzheimer's Treatment
Neuroinmmunomodulation in neurodegenerative diseases: New scientific evidence [La teoría de la neuroinmunomodulación en enfermedades neurodegenerativas: Nuevas evidencias científicas]
Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches
Neuroinflammation in the pathogenesis of Alzheimer's disease. A rational framework for the search of novel therapeutic approaches.
Nutraceuticals: a novel concept in prevention and treatment of Alzheimer's disease and related disorders.
Tau Oligomers and Fibrils Induce Activation of Microglial Cells
Tau oligomers and fibrils induce activation of microglial cells.
Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs.
Fibrillar Amyloid-beta(1-42) Modifies Actin Organization Affecting the Cofilin Phosphorylation State: A Role for Rac1/cdc42 Effector Proteins and the Slingshot Phosphatase
Molecules of the Quinoline Family Block Tau Self-Aggregation: Implications Toward a Therapeutic Approach for Alzheimer's Disease
Platelet Tau Pattern Correlates with Cognitive Status in Alzheimer's Disease
Shilajit: A natural phytocomplex with potential procognitive activity
Fulvic Acid Inhibits Aggregation and Promotes Disassembly of Tau Fibrils Associated with Alzheimer's Disease
Human Platelet Tau: A Potential Peripheral Marker for Alzheimer's Disease
Mechanisms of tau self-aggregation and neurotoxicity
Molecular Targets in the Rational Design of AD Specific PET Tracers: Tau or Amyloid Aggregates?
Novel Drugs Affecting Tau Behavior in the Treatment of Alzheimer's Disease and Tauopathies
IL-3 Control Tau Modifications and Protects Cortical Neurons from Neurodegeneration
Neuroimmunomodulation in the Pathogenesis of Alzheimer's Disease
Selective Interaction of Lansoprazole and Astemizole with Tau Polymers: Potential New Clinical Use in Diagnosis of Alzheimer's Disease
CYCLIN-DEPENDENT KINASE 5 ACTIVATOR p35 OVER-EXPRESSION AND AMYLOID BETA SYNERGISM INCREASE APOPTOSIS IN CULTURED NEURONAL CELLS
In vivo effects of 3-iodocytisine: Pharmacological and genetic analysis of hypothermia and evaluation of chronic treatment on nicotinic binding sites
Tau Phosphorylation by cdk5 and Fyn in Response to Amyloid Peptide A beta(25-35): Involvement of Lipid Rafts
The Role of Neuroimmunomodulation in Alzheimer's Disease
Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism
Microtubule-associated protein 1B interaction with tubulin tyrosine ligase contributes to the control of microtubule tyrosination
Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron
The damage signals hypothesis of Alzheimer's disease pathogenesis
A beta(1-42) stimulates actin polymerization in hippocampal neurons through Rac1 and Cdc42 Rho GTPases
cdk5 Modulates beta- and delta-catenin/Pin1 interactions in neuronal cells
Interleukin-3 prevents neuronal death induced by amyloid peptide
Neuroprotective effect of TNF alpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase
Anomalously phosphorylated tau and A beta fragments in the CSF correlates with cognitive impairment in MCI subjects
Production of nerve growth factor by beta-amyloid-stimulated astrocytes induces p75(NTR)-dependent tau hyperphosphorylation in cultured hippocampal neurons
Tau protein binds to pericentromeric DNA: a putative role for nuclear tau in nucleolar organization
ApoE alleles and tau markers in patients with different levels of cognitive impairment
Role of the JAKs/STATs pathway in the intracellular calcium changes induced by interleukin-6 in hippocampal neurons
Astrocytic nitric oxide triggers tau hyperphosphorylation in hippocampal neurons
DIMENSIONES BIOÉTICAS DE LA INVESTIGACIÓN SOBRE EL GENOMA HUMANO
Effects of natural flavones and flavonols on the kinase activity of Cdk5
Interleukin-6 induces Alzheimer-type phosphorylation of tau protein by deregulating the cdk5/p35 pathway
Oxidative stress promotes T dephosphorylation in neuronal cells: The roles of cdk5 and pp1
Iron-activated iron uptake: A positive feedback loop mediated by iron regulatory protein 1
Iron-induced oxidative stress modify tau phosphorylation patterns in hippocampal cell cultures
Modulation of the JNK and p38 pathways by cdk5 protein kinase in a transgenic mouse model of Alzheimer's disease
New paradigms in the study of the pathogenesis of Alzheimer's disease Nuevos paradigmas en el estudio de la patogénesis de la enfermedad de Alzheimer
Nuevos paradigmas en el estudio de la patogénesis de la enfermedad de Alzheimer
Regulation of p27 in the process of neuroblastoma N2A differentiation
An oxidative stress-mediated positive-feedback iron uptake loop in neuronal cells
Tubulin, actin, and tau protein interactions and the study of their macromolecular assemblies
A cdk5-p35 stable complex is involved in the beta-amyloid-induced deregulation of cdk5 activity in hippocampal neurons
Expression pattern of DMAP-85 during Drosophila embryonic development
Differential association of tau with subsets of microtubules containing posttranslationally-modified tubulin variants in neuroblastoma cells
Differential association of tau with subsets of microtubules containing posttranslationally-modified tubulin variants in neuroblastoma cells.
Increase in the expression of the neuronal cyclin-dependent protein kinase cdk-5 during differentiation of N2A neuroblastoma cells
Increase in the expression of the neuronal cyclin-dependent protein kinase cdk-5 during differentiation of N2A neuroblastoma cells
Nuclear and cytoplasmic tau proteins from human nonneuronal cells share common structural and functional features with brain tau
Nuclear and cytoplasmic tau proteins from human nonneuronal cells share common structural and functional features with brain tau.
Inhibition of tau phosphorylating protein kinase cdk5 prevents beta-amyloid-induced neuronal death.
Regulatory roles of microtubule-associated proteins in neuronal morphogenesis. Involvement of the extracellular matrix.
The beta-isoform of heat shock protein hsp-90 is structurally related with human microtubule-interacting protein Mip-90.
Modification of tau to an Alzheimer's type protein interferes with its interaction with microtubules.
The association of tau-like proteins with vimentin filaments in cultured cells.
The compound 14-keto-stypodiol diacetate from the algae Stypopodium flabelliforme inhibits microtubules and cell proliferation in DU-145 human prostatic cells.
The interaction of Mip-90 with microtubules and actin filaments in human fibroblasts.
Immunological characterization of epitopes on tau of Alzheimer's type and chemically modified tau.
Tau-like proteins associated with centrosomes in cultured cells.
Tubulin domains for the interaction of microtubule associated protein DMAP-85 from Drosophila melanogaster.
A 205 kDa protein from non-neuronal cells in culture contains tubulin binding epitopes.
DMAP-85: a tau-like protein from Drosophila melanogaster larvae.
Functional organization of tau proteins during neuronal differentiation and development.
Identification of a new microtubule-interacting protein Mip-90.
Role of microtubule-associated proteins in the control of microtubule assembly.
Role of microtubule-associated proteins in the control of microtubule assembly.
Subpopulations of tau interact with microtubules and actin filaments in various cell types.
The secretion of urokinase-like plasminogen activator is inhibited by microtubule-interacting drugs.
Carboxyl terminal sequences of beta-tubulin involved in the interaction of HMW-MAPs. Studies using site-specific antibodies.
Purification and characterization of the high molecule weight microtubule associated proteins from neonatal rat brain.
A tau fragment containing a repetitive sequence induces bundling of actin filaments.
A tau-like protein interacts with stress fibers and microtubules in human and rodent cultured cell lines.
Functional domains on chemically modified tau protein.
Estramustine-phosphate binds to a tubulin binding domain on microtubule-associated proteins MAP-2 and tau.
Specific macromolecular interactions between tau and the microtubule system.
The antineoplastic agent estramustine and the derivative estramustine-phosphate inhibit secretion of interleukin-3 in leukemic cells. Possible roles of MAPs.
The antineoplastic agent estramustine and the derivative estramustine-phosphate inhibit secretion of interleukin-3 in leukemic cells. Possible roles of MAPs.
MAP-1 and MAP-2 binding sites at the C-terminus of beta-tubulin. Studies with synthetic tubulin peptides.
The solution conformation of tubulin-beta(422-434)-NH2 and its Nac-DATADEQG-NH2 fragment based on NMR.
Calmodulin binds to a tubulin binding site of the microtubule-associated protein tau.
Common antigenic determinants of the tubulin binding domains of the microtubule-associated proteins MAP-2 and tau.
A discrete repeated sequence defines a tubulin binding domain on microtubule-associated protein tau.
Biochemical dissection of the role of the one-kilodalton carboxyl-terminal moiety of tubulin in its assembly into microtubules.
Anti-idiotypic antibodies that react with microtubule-associated proteins are present in the sera of rabbits immunized with synthetic peptides from tubulin's regulatory domain.
Antibodies to synthetic peptides from the tubulin regulatory domain interact with tubulin and microtubules.
Differential interaction of synthetic peptides from the carboxyl-terminal regulatory domain of tubulin with microtubule-associated proteins.
Heat-stable microtubule protein MAP-1 binds to microtubules and induces microtubule assembly.
Small zone gel chromatography of interacting systems: theoretical and experimental evaluation of elution profiles for kinetically controlled macromolecule-ligand reactions.
A proton magnetic resonance and a circular dichroism study of the solvent dependent conformation of the synthetic tubulin fragment Ac tubulin, alpha (430-441) amide and its interaction with substance-P.
Regulatory aspects of the colchicine interactions with tubulin.
Characterization and structural aspects of the enhanced assembly of tubulin after removal of its carboxyl-terminal domain.
Interaction of substance P with tubulin.
Transglutaminase and neuronal differentiation.
Controlled proteolysis of tubulin by subtilisin: localization of the site for MAP2 interaction.
Involvement of the carboxyl-terminal domain of tubulin in the regulation of its assembly.
Affinity labeling of tubulin's exchangeable guanosine 5'-triphosphate binding site.
Limited proteolysis of tubulin: nucleotide stabilizes an active conformation.
Microtubule assembly affected by the presence of denatured tubulin.
Involvement of tryptophan residues in colchicine binding and the assembly of tubulin.
Residual nucleotide and tubulin's ability to polymerize with nucleotide analogs.
Tubulin carbamoylation. Functional amino groups in microtubule assembly.
Arginyl residues involvement in the microtubule assembly.
Selective modification of fructose 1,6-bisphosphatase by periodate-oxidized AMP.
Enhancement of tubulin assembly as monitored by a rapid filtration assay.
Proteins from morphologically differentiated neuroblastoma cells promote tubulin polymerization.
ApoE alleles and tau markers in patients with different levels of cognitive impairment.
Opinion on the journal.
Opinion on the journal.
The molecular bases of Alzheimer's disease and other neurodegenerative disorders.

Abstract (12)

Tau Platelets Biomarker Correlates with Clinical Features of Alzheimer's Disease
Might paretin have effect against tau protein?
Tau Oligomers Promote Microglial Activation. The Neuroimmunomodulation Hypothesis of Alzheimer's Disease (AD)
DEREGULATION OF p27 PROTEIN IN THE NEUROBLASTOMA N2A
Phosphorylation dependent control of oxidative modification in Alzheimer disease
Phosphorylation modulated oxidative modification of neurofilament protein.
A beta PP transgenic mice Tg2576 induces Cdk5-dependent tau hyperphosphorylation
Interleukin-3 promotes neuronal survival in mouse neuroblastoma N2A cells
Interleukin-6 induces Alzheimer's type phosphorylation of tau protein by the cdk5/p35 pathway
Iron and oxidative stress: A positive-feedback iron uptake loop in neuronal cells.
Regulation of brain tau phosphorylation by the CDK5/P35 system under oxidative stress and iron overload conditions
Regulation of tau protein by cdk5 during neuritic development

BookSection (2)

The Promise for Alzheimer Disease Treatment. Bioactive Compounds
Pore forming neurotoxin-like mechanism for Aβ-induced synaptic failure.

BookWhole (1)

Current hypotheses and research milestones in Alzheimer's disease

ConferencePaper (2)

Central Nervous System Inflammation and Cholesterol Metabolism Alterations in the Pathogenesis of Alzheimer's Disease and Their Diagnostic and Therapeutic Implications
What Have We Learned from the Tau Hypothesis?

EditorialMaterial (5)

Pathway to Tau Modifications and the Origins of Alzheimers Disease
SPECIAL ISSUE Alzheimer Disease Introductory Remarks
The Revitalized Tau Hypothesis on Alzheimer's Disease
Regulation of brain tau phosphorylation by the CDK5/P35 complex under oxidative stress conditions
Cdk5

Letter (1)

Opinion on the journal

Patent (5)

New compounds derived from piridinmetilsulfinilbenzoxazoles and piridinmetilsulfinibenzotiazoles, radiolabelled or fluorescently and compositions, as specific biomarkers for the diagnosis of neurodegenerative diseases and involved in tau protein diseases.
Innovative blood platelets biomarker for early diagnosis of alzheimer's disease Abstract
Method for inhibiting tau protein aggregation and treatment of alzheimer's disease with a compound derived from quinoline
Benzimidazole-derived compounds used as markers in the case of neurodegenerative diseases
Nutraceutical composition that comprises extract of shilajit, folic acid, vitamin B12 and vitamin B6 and the use thereof for preventing and/or treating neurodegenerative diseases and/or the cognitive deterioration associated with cerebral ageing.

Proyecto (20)

Advanced clinical trials and molecular composition of the internationally-positioned formula BrainUp-10
EMPAQUETAMIENTO DEL NUTRACEUTICO BRAIN UP-10
CELLULAR AND MOLECULAR ASPECTS OF NEUROIMMUNOMODULATION IN THE ALZHEIMER S TYPE NEURONAL DEGENERATION
PROTOTIPO DE KIT DE DIAGNÓSTICO USANDO BIOMARCADOR NO INVASIVO PARA LA DETECCIÓN TEMPRANA DE LA ENFERMEDAD DE ALZHEIMER
Technology transfer of nutraceutical products of economical relevance for Chile
Validation of neuropsychological tests and biomarkers for the diagnosis of mild Alzheimer Disease
Benzimidazoles as neuroimaging radiotracers for early diagnosis of Alzheimer´s disease
Search for tau binding molecules as radiotracer for neuroimaging of Alzheimer´s disease
International Cooperation for Centers of Excellence
Biological basis of neurodegenrative disorders: an integrative view of the cellular and molecular signals que control neuron-glia interactions
Design, synthesis and evaluation of possible subtype-selective agonits and allosteric modulators of nicotinic acetylcholine receptors
Millennium Institute for Advanced Studies in Cell Biology and Biotechnology (CBB)
Celullar and molecular basis of neurodegenerative disorders
Studies at the cellular and molecular levels of neuronal differentiation
SEEDS PROJECT FOR IMPROVEMENT OF EDUCATION IN BIOLOGICAL SCIENCES
Regulatory functions of microtubule associated proteins in the cytoskeleton organization
Genesis of paired helical filaments (PHF) in the Alzheimer´s disease
Studies on the regulatory roles of DMAP-85 on the dynamics of microtubules. Moculation by kinases
Roles of microtubule associated protein tau in the regulation of the cytoskeletal filamentous network
Celullar and molecular basis of neurodegenerative disorders: an integrative view from the perspective of the neuronal cytoskeleton

Review (11)

Behavioral and Neuropsychiatric Disorders in Alzheimers Disease
Neuroimmune Tau Mechanisms: Their Role in the Progression of Neuronal Degeneration
Nutraceuticals: A Novel Concept in Prevention and Treatment of Alzheimer's Disease and Related Disorders
Tau oligomers as potential targets for Alzheimer's diagnosis and novel drugs
Can Nutraceuticals Prevent Alzheimer's Disease? Potential Therapeutic Role of a Formulation Containing Shilajit and Complex B Vitamins
Emerging Noninvasive Biomarkers for Early Detection of Alzheimer's Disease
Insulin Resistance and Alzheimer's Disease: Molecular Links & Clinical Implications
Neuroinflammation: Implications for the pathogenesis and molecular diagnosis of Alzheimer's disease
Roles of cholesterol and lipids in the etiopathogenesis of Alzheimer's disease
The molecular bases of Alzheimer's disease and other neurodegenerative disorders
The protein kinase Cdk5 - Structural aspects, roles in neurogenesis and involvement in Alzheimer's pathology
114
Ricardo Maccioni

DIRECTOR

RESEARCH AND DEVELOPMENT

CENTRO INTERNACIONAL DE BIOMEDICINA (ICC)

SANTIAGO, Chile

13
Gonzalo Farías

Profesor Asistente

Departamento de Neurología y Neurocirugía Norte y Departamento de Neurociencias

Facultad de Medicina, Universidad de Chile

Santiago, Chile

12
Christian Gonzalez

Full Professor

Biology

Universidad de Chile

Santiago, Chile

12
Leonardo Guzman

Investigador Asociado

Diagnóstico

Centro Internacional de Biomedicina ICC

Santiago, Chile

11
Leonel Rojo

Profesor Asociado

Departamento de Biología

Universidad de Santiago de Chile

Estación Central, Chile

7
Angara Zambrano

Assistant Professor

Biochemistry and Microbiology

UNIVERSIDAD AUSTRAL DE CHILE

Valdivia, Chile

7
CAROLA OTTH

profesor titular

microbiologia clinica

UNIVERSIDAD AUSTRAL DE CHILE. FACULTAD DE MEDICINA. INSTITUTO DE MICROBIOLOGIA CLINICA

VALDIVIA, Chile

5
Rodrigo Quintanilla

Associate professor

Universidad Autónoma de Chile

Santiago, Chile

5
Patricio Fuentes

Medico Neurologo

Medicina

Hospital Clínico Universidad de Chile

Santiago, Chile

4
Marco Nuñez

Professor

Biology

Fac. Ciencias, Universidad de Chile

Santiago, Chile

4
José Jiménez

Postdoc

Investigación

Fundacion Ciencia y Vida

Santiago, Chile

3
Marcela Sjoberg

Assistant professor

Biología Celular y Molecular

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

3
Andrea Slachevsky

Associate Professor

ICBM

UNIVERSIDAD DE CHILE

Chile, Chile

3
Nicole Cortés

Coordinadora de Estudios Clínicos

Laboratorio de Biología Celular, Molecular y Neurociencias, Corporación Centro Internacional de Biomedicina, ICC

Santiago, Chile

2
Jose Egana

Profesor asistente

Instituto de Ingeniería Biológica y Médica

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

Santiago, Chile

2
Andrea González

Investigadora Asociada

CENTRO INTERNACIONAL DE BIOMEDICINA (ICC)

Santiago, Chile

2
Karen Neumann

PhD

Producción Animal

Universidad de Chile

Santiago, Chile

2
Elias Utreras

Profesor Asistente

Biologia

Universidad de Chile

Santiago, Chile

2
Leonardo Navarrete

Jefe de Laboratorio

Centro Internacional de Biomedicina

Santiago, Chile

2
CAROLINA DELGADO

ASSOCIATE PROFESSOR

NEUROLOGÍA y neurocirugía

HOSPITAL CLINICO UNIVERSIDAD DE CHILE

SANTIAGO, Chile

1
Gerald Zapata

DEPARTAMENTO DE QUÍMICA INORGÁNICA Y ANALÍTICA FACULTAD DE CIENCIAS QUÍMICAS Y FARMACÉUTICAS UNIVERSIDAD DE CHILE

Santiago, Chile

1
Carolina Mascayano

Académico

Ciencias del Ambiente

UNIVERSIDAD DE SANTIAGO DE CHILE, FACULTAD DE QUÍMICA Y BIOLOGIA

santiago, Chile

1
Pablo Gaspar

Profesor Asistente

Psiquiatria Norte

Universidad de Chile

santiago, Chile

1
Luis Aguayo

Full Professor

Department of Physiology

Universidad de Concepcion

Concepcion, Chile

1
Felipe Opazo

Group Leader

Center for Biostructural Imaging of Neuodegeneration (BIN)

Göttingen, Alemania

1
Francisco Melo

FULL PROFESSOR

FISICA

UNIVERSIDAD DE SANTIAGO DE CHILE

SANTIAGO, Chile

1
Rodrigo Kuljis

Founder and President

Office of the President

Zdrav Mozak Limitada

Santiago, Chile

1
Fernando Crespo

Director

Facultad de Ingeniería, Ciencias y Tecnología

Universidad Bernardo O'Higgins

Santiago, Chile

1
Maria Sekler

Investigadora

Neuroinnovation Ltda

Santiago, Chile

1
Fernando Crespo

Académico e Investigador

DAiTA LAB

Universidad Mayor de Chile

Santiago, Chile

1
Veronica Cambiazo

Associate Professor

Unidad de Nutrición Básica

UNIVERSIDAD DE CHILE - INTA

Santiago, Chile

1
Jans Alzate

Associate Professor

Departamento de Bioinformática

UNIVERSIDAD DE TALCA

Talca, Chile

1
Edgar Pastene

Profesor

Ciencias Básias

Universidad del Bío-Bío

Chillán, Chile

1
Marcela Mancilla

Docente

Ciencias Básicas

Universidad de Viña del Mar

Viña del Mar, Chile

1
AURELIO SAN MARTIN

Profesor Asociado (media jornada)

de Ciencias y Recursos Naturales

FACULTAD DE CIENCIAS

Punta Arenas, Chile

1
Daniel Henriquez

Director Ciencia Transversal

Fundación Centro MERI

Santiago, Chile

1
José Tapia

Ingeniero de Proyectos

Corporación Centro Internacional de Biomedicina

Santiago, Chile

1
Mauricio Gonzalez

Profesor Titular

INTA

UNIVERSIDAD DE CHILE - INSTITUTO DE NUTRICION Y TECNOLOGIA DE ALIMENTOS

Santiago, Chile